CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale EVP,General Counsel, Secretary sold 917 shares at $21.18 ($19,422)
- 4 Open-market sale EVP, COO, Head of Commercial sold 548 shares at $21.18 ($11,607)
- 4 Open-market sale CEO sold 7,806 shares at $21.18 ($165,331)
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 4 Open-market sale Principal Accounting Officer sold 523 shares at $18.14 ($9,487)
- 4 Open-market sale EVP, COO, Head of Commercial sold 1,751 shares at $18.16 ($31,798)
- 4 Open-market sale Principal Accounting Officer sold 701 shares at $18.16 ($12,730)
- 4 Open-market sale EVP, Chief Financial Officer sold 1,916 shares at $18.16 ($34,795)
- 4 Open-market sale CEO sold 8,582 shares at $18.16 ($155,849)
- 4 Open-market sale EVP,General Counsel, Secretary sold 1,456 shares at $18.16 ($26,441)
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Principal Accounting Officer sold 350 shares at $18.78 ($6,573)
- 4 Open-market sale EVP, Chief Financial Officer sold 577 shares at $18.78 ($10,836)
- 4 Open-market sale CEO sold 3,851 shares at $18.78 ($72,322)
Page 13 of 70 · 1,382 filings